U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Substance Class Protein
Created
by admin
on Mon Mar 31 20:36:48 GMT 2025
Edited
by admin
on Mon Mar 31 20:36:48 GMT 2025
Protein Type MONOCLONAL ANTIBODY
Protein Sub Type IGG2A
Sequence Origin MOUSE
Sequence Type COMPLETE
Record UNII
K1KT5M40JC
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
TOSITUMOMAB I-131
Common Name English
TOSITUMOMAB IODINE-131
VANDF  
Preferred Name English
IODINE I131 TOSITUMOMAB
Common Name English
TOSITUMOMAB, I-131
Common Name English
IODINE-131 ANTI-B1 ANTIBODY
Common Name English
TOSITUMOMAB IODINE-131 [VANDF]
Common Name English
IODINE (131I) TOSITUMOMAB
Common Name English
IODINE-131-TOSITUMOMAB
Common Name English
BEXXAR COMPONENT IODINE I 131 TOSITUMOMAB
Common Name English
TOSITUMOMAB CONJUGATE WITH 131I [MI]
Common Name English
ANTI-B1 ANTIBODY I-131
Common Name English
IODINE I 131 TOSITUMOMAB
Common Name English
Tositumomab-iodine 131 [WHO-DD]
Common Name English
BEXXAR
Brand Name English
131I-TOSITUMOMAB
Common Name English
TOSITUMOMAB-IODINE 131
WHO-DD  
Common Name English
TOSITUMOMAB I 131
Common Name English
Classification Tree Code System Code
NDF-RT N0000175658
Created by admin on Mon Mar 31 20:36:48 GMT 2025 , Edited by admin on Mon Mar 31 20:36:48 GMT 2025
NDF-RT N0000175078
Created by admin on Mon Mar 31 20:36:48 GMT 2025 , Edited by admin on Mon Mar 31 20:36:48 GMT 2025
WHO-ATC V10XA53
Created by admin on Mon Mar 31 20:36:48 GMT 2025 , Edited by admin on Mon Mar 31 20:36:48 GMT 2025
NDF-RT N0000000205
Created by admin on Mon Mar 31 20:36:48 GMT 2025 , Edited by admin on Mon Mar 31 20:36:48 GMT 2025
NCI_THESAURUS C129819
Created by admin on Mon Mar 31 20:36:48 GMT 2025 , Edited by admin on Mon Mar 31 20:36:48 GMT 2025
EU-Orphan Drug EU/3/03/136
Created by admin on Mon Mar 31 20:36:48 GMT 2025 , Edited by admin on Mon Mar 31 20:36:48 GMT 2025
FDA ORPHAN DRUG 79493
Created by admin on Mon Mar 31 20:36:48 GMT 2025 , Edited by admin on Mon Mar 31 20:36:48 GMT 2025
WHO-VATC QV10XA53
Created by admin on Mon Mar 31 20:36:48 GMT 2025 , Edited by admin on Mon Mar 31 20:36:48 GMT 2025
NCI_THESAURUS C1511
Created by admin on Mon Mar 31 20:36:48 GMT 2025 , Edited by admin on Mon Mar 31 20:36:48 GMT 2025
Code System Code Type Description
MERCK INDEX
m10983
Created by admin on Mon Mar 31 20:36:48 GMT 2025 , Edited by admin on Mon Mar 31 20:36:48 GMT 2025
PRIMARY Merck Index
FDA UNII
K1KT5M40JC
Created by admin on Mon Mar 31 20:36:48 GMT 2025 , Edited by admin on Mon Mar 31 20:36:48 GMT 2025
PRIMARY
RXCUI
234449
Created by admin on Mon Mar 31 20:36:48 GMT 2025 , Edited by admin on Mon Mar 31 20:36:48 GMT 2025
PRIMARY RxNorm
SMS_ID
100000091710
Created by admin on Mon Mar 31 20:36:48 GMT 2025 , Edited by admin on Mon Mar 31 20:36:48 GMT 2025
PRIMARY
LACTMED
Tositumomab I 131
Created by admin on Mon Mar 31 20:36:48 GMT 2025 , Edited by admin on Mon Mar 31 20:36:48 GMT 2025
PRIMARY
DRUG BANK
DB00081
Created by admin on Mon Mar 31 20:36:48 GMT 2025 , Edited by admin on Mon Mar 31 20:36:48 GMT 2025
PRIMARY
NCI_THESAURUS
C2444
Created by admin on Mon Mar 31 20:36:48 GMT 2025 , Edited by admin on Mon Mar 31 20:36:48 GMT 2025
PRIMARY
EVMPD
SUB26262
Created by admin on Mon Mar 31 20:36:48 GMT 2025 , Edited by admin on Mon Mar 31 20:36:48 GMT 2025
PRIMARY
CAS
192391-48-3
Created by admin on Mon Mar 31 20:36:48 GMT 2025 , Edited by admin on Mon Mar 31 20:36:48 GMT 2025
PRIMARY
Related Record Type Details
TARGET -> INHIBITOR
TARGET -> AGONIST
STARTING MATERIAL -> INGREDIENT
Related Record Type Details
ACTIVE MOIETY

Agent Modifications

Modification Process Modification Role Modification Type Amount Fragment Name Fragment ID
RADIOLABELLING RADIOLABEL CHEMICAL IODINE I-131 I5X6L61HUT
Name Property Type Amount Referenced Substance Defining Parameters References
MOL_WEIGHT:NUMBER(CALCULATED) CHEMICAL
Molecular Formula CHEMICAL